Biomarker Predicts Colon Cancer Risk in Ulcerative Colitis

(MedPage Today) -- Testing for somatic genomic copy number alterations (CNAs) in ulcerative colitis patients with low-grade dysplasia was able to predict risk of advanced neoplasia more accurately than other currently used pathological features...